Enveric Biosciences’ (NASDAQ:ENVB) wholly-owned subsidiary, Akos Biosciences, Inc., entered into two licensing agreements ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

Acquisition to strengthen key pillar of BioNTech’s oncology strategy aimed at establishing BNT327 as a pan-tumor technology platformfor the ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

A Purdue University researcher has created and validated a patent-pending free-flying robotic centrifuge system called GRAVI-BOT for research and process applications in crewed spaceflight.

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

Thermo Fisher is a Life Sciences giant with over $42 billion in yearly revenues and 120 thousand employees. Find out why I ...

Paper mills’ are contaminating the world’s scholarly output with fake papers that hinder research. Lifesaving biomedical ...

Nermine Qotb describes the sometimes difficult journey that patent-seekers must undertake when seeking to register their ...

(Nasdaq: NASDAQ:RVNC), two biotechnology firms, have announced a collaboration to start a Phase 2a ... The trial will assess the efficacy of a combined topical application of Dermata's product, ...

(Nasdaq: NASDAQ:RVNC), two biotechnology firms, have announced a collaboration to start a Phase 2a ... The trial will assess the efficacy of a combined topical application of Dermata’s product, ...